Andrea Difabio
General Counsel at Xenon Pharmaceuticals Inc. (XENE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $231K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 13SEC | XENEXenon Pharmaceuticals Inc. | Sell Plan | 1,3427,301 held (−16%) | $55.23 | $74K | -39.4% |
| Mar 11SEC | XENEXenon Pharmaceuticals Inc. | Sell Plan | 2,6074,893 held (−35%) | $60.11 | $157K | -44.3% |
- Sell
General Counsel Andrea Difabio sold $74K of XENE at $55.23 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Andrea Difabio sold $157K of XENE at $60.11 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.